Hyaluronidases and their inhibitors in the serum of colorectal carcinoma patients

    loading  Checking for direct PDF access through Ovid


Colorectal cancer is the third most commonly diagnosed type of cancer. Hyaluronan is involved in this malignancy. Moreover, hyaluronidases – its degrading enzymes – display controversial roles regarding their involvement in tumor development. HYAL-1 is the major tumor derived hyaluronidase. The aim of the study was the determination and evaluation of hyaluronidase levels in serum of colorectal cancer patients, before and after surgery, with a view to assessing its potential role as a tumor marker for recurrence. By zymography and Western blotting, it was confirmed that HYAL-1 was the only hyaluronidase present in samples. Quantification of its activity indicated a statistically significant decrease in samples seven days postoperatively, compared with the respective ones before surgery. HYAL-1 levels before surgery were significantly reduced in comparison with healthy samples and samples one year postoperatively. Hyaluronidase inhibitor activity was demonstrated under mild alkaline conditions via reverse zymography. A statistically significant increase was observed in samples seven days postoperatively, when compared with samples before surgery. HYAL-1 levels in sera of colorectal cancer patients were lower than those of healthy population, possibly because of the local accumulation of the enzyme in tumor microenvironment. A gradual elevation up to one year postoperatively to reach healthy levels might indicate a role of HYAL-1 levels in cancer.

Graphical abstract

HYAL-1 activity in sera of CRC patients: Quantification of HYAL-1 activity (buffer pH 3.7) in sera obtained from normal population (N) and CRC patients one day before operation (D-1), one week (D + 7) and one year (D + Y) postoperatively. Single asterisk indicates statistical difference with normal population (p < 0.05). Double asterisk indicates statistical difference with sera obtained one day preoperatively (p < 0.01).

Related Topics

    loading  Loading Related Articles